Michelle Kelly - National Health VP Investments
| WX6 Stock | EUR 73.50 0.50 0.68% |
Insider
Michelle Kelly is VP Investments of National Health Investors
| Phone | 615-890-9100 |
| Web | https://www.nhireit.com |
Michelle Kelly Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michelle Kelly against National Health stock is an integral part of due diligence when investing in National Health. Michelle Kelly insider activity provides valuable insight into whether National Health is net buyers or sellers over its current business cycle. Note, National Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell National Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michelle Kelly over a month ago Acquisition by Michelle Kelly of 10695 shares of Oxford Industries subject to Rule 16b-3 |
National Health Management Efficiency
The company has return on total asset (ROA) of 0.0336 % which means that it generated a profit of $0.0336 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0467 %, meaning that it generated $0.0467 on every $100 dollars invested by stockholders. National Health's management efficiency ratios could be used to measure how well National Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 7 records | INSIDER Age | ||
| Matthew Mazdyasni | Apollo Medical Holdings | 62 | |
| Christoph Nowak | Diamyd Medical AB | 37 | |
| Anna BSc | Diamyd Medical AB | 62 | |
| Ulf MBA | Diamyd Medical AB | 48 | |
| Anton Lindqvist | Diamyd Medical AB | 43 | |
| Martina Widman | Diamyd Medical AB | 42 | |
| Eva Karlstrom | Diamyd Medical AB | 59 | |
Management Performance
| Return On Equity | 0.0467 | |||
| Return On Asset | 0.0336 |
National Health Investors Leadership Team
Elected by the shareholders, the National Health's board of directors comprises two types of representatives: National Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of National. The board's role is to monitor National Health's management team and ensure that shareholders' interests are well served. National Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, National Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dana Hambly, Director Relations | ||
| David Travis, VP Officer | ||
| Kimberly Ouimet, Director HR | ||
| John Spaid, Exec CFO | ||
| Colleen Schaller, Real Mang | ||
| Eric Mendelsohn, CEO Pres | ||
| Michelle Kelly, VP Investments | ||
| Kristin Gaines, Chief Officer | ||
| Kevin Pascoe, Chief Officer | ||
| Susan Sidwell, Co Sec |
National Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is National Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0467 | |||
| Return On Asset | 0.0336 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.52 % | |||
| Current Valuation | 3.32 B | |||
| Shares Outstanding | 43.39 M | |||
| Shares Owned By Insiders | 4.77 % | |||
| Shares Owned By Institutions | 63.16 % | |||
| Price To Earning | 19.80 X | |||
| Price To Book | 1.86 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in National Stock
When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.